Podium to Practice: Chicago 2026 – LUNG: ALCHEMIST
OR
Studies / Trials Discussed
8000 – Randomized phase III study of nivolumab after surgery and adjuvant chemotherapy in NSCLC (ECOG-ACRIN EA5142, ALCHEMIST).
Chair
Explore more from your favourite experts – click their name to access their entire library of content.
Studies/trials discussed:
8000 – Randomized phase III study of nivolumab after surgery and adjuvant chemotherapy in NSCLC (ECOG-ACRIN EA5142, ALCHEMIST).
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.